U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Juvenile hyaline fibromatosis(JHF)

MedGen UID:
411197
Concept ID:
C2745948
Disease or Syndrome
Synonyms: Hyalinosis, systemic juvenile; JHF; Puretic syndrome
SNOMED CT: Juvenile hyaline fibromatosis (238861002); Puretic syndrome (238861002); Systemic hyalinosis (238861002); Murray Puretic Drescher syndrome (238861002)
Modes of inheritance:
Autosomal recessive inheritance
MedGen UID:
141025
Concept ID:
C0441748
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in individuals with two pathogenic alleles, either homozygotes (two copies of the same mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele).
 
Monarch Initiative: MONDO:0016071
Orphanet: ORPHA2028

Disease characteristics

Excerpted from the GeneReview: Hyaline Fibromatosis Syndrome
Hyaline fibromatosis syndrome (HFS) is characterized by hyaline deposits in the papillary dermis and other tissues. It can present at birth or in infancy with severe pain with movement, progressive joint contractures, and often with severe motor disability, thickened skin, and hyperpigmented macules/patches over bony prominences of the joints. Gingival hypertrophy, skin nodules, pearly papules of the face and neck, and perianal masses are common. Complications of protein-losing enteropathy and failure to thrive can be life threatening. Cognitive development is normal. Many children with the severe form (previously called infantile systemic hyalinosis) have a significant risk of morbidity or mortality in early childhood; some with a milder phenotype (previously called juvenile hyaline fibromatosis) survive into adulthood. [from GeneReviews]
Authors:
Joseph TC Shieh  |  H Eugene Hoyme  |  Laura T Arbour   view full author information

Additional description

From MedlinePlus Genetics
Hyaline fibromatosis syndrome is a disorder in which a clear (hyaline) substance abnormally accumulates in body tissues. This disorder affects many areas of the body, including the skin, joints, bones, and internal organs. The severity of the signs and symptoms of hyaline fibromatosis syndrome fall along a spectrum. In more severe cases (previously diagnosed as infantile systemic hyalinosis), signs and symptoms are present at birth or begin within the first few months of life and can be life-threatening. In milder cases (previously diagnosed as juvenile hyaline fibromatosis), signs and symptoms begin in childhood and affect fewer body systems.

One of the main features of hyaline fibromatosis syndrome is the growth of noncancerous masses of tissue (nodules) under the skin, very commonly on the scalp. In more severely affected individuals, nodules also grow in the muscles and internal organs, causing pain and complications. Some severely affected individuals develop a condition called protein-losing enteropathy due to the formation of nodules in their intestines. This condition results in severe diarrhea, failure to gain weight and grow at the expected rate, and general wasting and weight loss (cachexia).

Another common feature of hyaline fibromatosis syndrome is painful skin bumps that frequently appear on the hands, neck, scalp, ears, and nose. They can also develop in joint creases and the genital region. These skin bumps are described as white or pink and pearly. They may be large or small and often increase in number over time.

In some affected individuals, especially those with more severe signs and symptoms, the skin covering joints, such as the ankles, wrists, elbows, and finger joints, is unusually dark (hyperpigmented). Hyaline fibromatosis syndrome is also characterized by overgrowth of the gums (gingival hypertrophy), and some affected individuals have thickened skin.

Joint stiffness and pain are common in hyaline fibromatosis syndrome, and many affected individuals develop joint deformities called contractures that limit movement. By adulthood, some people with the condition require a wheelchair for mobility. Bone abnormalities can also occur in hyaline fibromatosis syndrome.

Although individuals with hyaline fibromatosis syndrome have severe physical limitations, mental development is typically normal. People with milder signs and symptoms live into adulthood, while the most severely affected individuals often do not survive beyond early childhood due to chronic diarrhea and recurrent infections.  https://medlineplus.gov/genetics/condition/hyaline-fibromatosis-syndrome

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVJuvenile hyaline fibromatosis

Professional guidelines

PubMed

Yasuda A, Miyazawa N, Inoue E, Imai T, Shionoya Y, Nakamura K
Anesth Prog 2021 Jun 1;68(2):117-118. doi: 10.2344/anpr-68-01-04. PMID: 34185859Free PMC Article
Casas-Alba D, Martínez-Monseny A, Pino-Ramírez RM, Alsina L, Castejón E, Navarro-Vilarrubí S, Pérez-Dueñas B, Serrano M, Palau F, García-Alix A
Hum Mutat 2018 Dec;39(12):1752-1763. Epub 2018 Sep 17 doi: 10.1002/humu.23638. PMID: 30176098

Recent clinical studies

Etiology

Yonel Z, Parma S, Chapple IL
Dent Update 2015 Sep;42(7):656-8, 660-2, 665-6. doi: 10.12968/denu.2015.42.7.656. PMID: 26630863
Çam B, Kurkcu M, Ozturan S, Haytac C, Uguz A, Ogden G
Int J Dermatol 2015 Feb;54(2):217-21. Epub 2014 Feb 10 doi: 10.1111/ijd.12033. PMID: 24506420
Thway K, Gibson S, Ramsay A, Sebire NJ
Pediatr Dev Pathol 2009 Jul-Aug;12(4):292-6. doi: 10.2350/08-07-0506.1. PMID: 18939887
Malathi BG, Prabha CV, Padma SR, Muley PR, Jeyachandran P
Indian J Pathol Microbiol 2006 Apr;49(2):257-9. PMID: 16933730
Quintal D, Jackson R
Arch Dermatol 1985 Aug;121(8):1062-3. PMID: 4026346

Diagnosis

Dukan R, Petroni G, Bruneval P, Pannier S, Masmejean EH
J Hand Surg Am 2022 Feb;47(2):195.e1-195.e5. Epub 2021 Mar 14 doi: 10.1016/j.jhsa.2020.12.013. PMID: 33726934
Song L, Yang J, Liu J, Wang J
Ann Diagn Pathol 2021 Dec;55:151835. Epub 2021 Sep 30 doi: 10.1016/j.anndiagpath.2021.151835. PMID: 34624626
Folpe AL, Schoen M, Kang S
Mayo Clin Proc 2020 Feb;95(2):328-329. doi: 10.1016/j.mayocp.2019.11.021. PMID: 32029086
Ravikumar VR, Veerappan Ramamoorthi RG, Manisankar S
Indian J Pathol Microbiol 2019 Apr-Jun;62(2):300-302. doi: 10.4103/IJPM.IJPM_76_17. PMID: 30971561
Aldred MJ, Crawford PJ
Oral Surg Oral Med Oral Pathol 1987 Jan;63(1):71-7. doi: 10.1016/0030-4220(87)90343-4. PMID: 2433666

Therapy

Shimizu K, Ogawa F, Hamasaki Y, Murota H, Katayama I
J Dermatol 2005 Aug;32(8):650-3. doi: 10.1111/j.1346-8138.2005.tb00816.x. PMID: 16334866
Kawasaki G, Yanamoto S, Mizuno A, Fujita S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001 Feb;91(2):200-4. doi: 10.1067/moe.2001.112156. PMID: 11174598

Prognosis

Song L, Yang J, Liu J, Wang J
Ann Diagn Pathol 2021 Dec;55:151835. Epub 2021 Sep 30 doi: 10.1016/j.anndiagpath.2021.151835. PMID: 34624626
Härter B, Benedicenti F, Karall D, Lausch E, Schweigmann G, Stanzial F, Superti-Furga A, Scholl-Bürgi S
Mol Genet Genomic Med 2020 Jun;8(6):e1203. Epub 2020 Mar 20 doi: 10.1002/mgg3.1203. PMID: 32196989Free PMC Article
Ravikumar VR, Veerappan Ramamoorthi RG, Manisankar S
Indian J Pathol Microbiol 2019 Apr-Jun;62(2):300-302. doi: 10.4103/IJPM.IJPM_76_17. PMID: 30971561
Casas-Alba D, Martínez-Monseny A, Pino-Ramírez RM, Alsina L, Castejón E, Navarro-Vilarrubí S, Pérez-Dueñas B, Serrano M, Palau F, García-Alix A
Hum Mutat 2018 Dec;39(12):1752-1763. Epub 2018 Sep 17 doi: 10.1002/humu.23638. PMID: 30176098
Aldred MJ, Crawford PJ
Oral Surg Oral Med Oral Pathol 1987 Jan;63(1):71-7. doi: 10.1016/0030-4220(87)90343-4. PMID: 2433666

Clinical prediction guides

Rahvar M, Teng J, Kim J
Am J Dermatopathol 2016 May;38(5):e60-3. doi: 10.1097/DAD.0000000000000467. PMID: 26885603
Mestiri S, Labaied N, Mama N, Ayadi A, Ladib M, Sriha B, Krifa H, Mokni M
Pathologica 2014 Jun;106(2):70-2. PMID: 25291871
Dowling O, Difeo A, Ramirez MC, Tukel T, Narla G, Bonafe L, Kayserili H, Yuksel-Apak M, Paller AS, Norton K, Teebi AS, Grum-Tokars V, Martin GS, Davis GE, Glucksman MJ, Martignetti JA
Am J Hum Genet 2003 Oct;73(4):957-66. Epub 2003 Sep 12 doi: 10.1086/378781. PMID: 12973667Free PMC Article
Rahman N, Dunstan M, Teare MD, Hanks S, Edkins SJ, Hughes J, Bignell GR, Mancini G, Kleijer W, Campbell M, Keser G, Black C, Williams N, Arbour L, Warman M, Superti-Furga A, Futreal PA, Pope FM
Am J Hum Genet 2002 Oct;71(4):975-80. Epub 2002 Sep 4 doi: 10.1086/342776. PMID: 12214284Free PMC Article
Mancini GM, Stojanov L, Willemsen R, Kleijer WJ, Huijmans JG, van Diggelen OP, de Klerk JB, Vuzevski VD, Oranje AP
Dermatology 1999;198(1):18-25. doi: 10.1159/000018058. PMID: 10026396

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...